ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Targeting the PI3K/Akt/mTOR and Nrf2 signaling axis with berberine: a novel strategy for attenuating diabetic cardiomyopathy.
Omnia Ameen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.